Quick answer for B2B buyers: A supplement positioned for consumers interested in GLP-1-related nutrition is not a GLP-1 medicine. Start with lawful positioning, ingredient eligibility, a realistic serving and a documented quality plan. Do not promise the effects of a prescription drug.
Define the Product Before Requesting a Capsule Quote
State the destination market, sales channel, intended audience, ingredient direction, capsule count, packaging and first-order volume. Separate nutritional support positioning from claims about treating obesity or replacing medication. Market-specific professional review should occur before artwork approval.
Specification and Document Checklist
| Decision | Evidence to approve |
|---|---|
| Ingredient identity | Full composition, source, assay basis and batch certificate of analysis |
| Serving and capsule capacity | Per-serving quantities, capsule size, fill weight and feasible daily capsule count |
| Quality controls | Agreed contaminant, microbiological and finished-product release specifications |
| Stability | Packaging assumptions, storage conditions and shelf-life support |
| Label and positioning | Destination-market ingredient and claim review, warnings and accurate serving information |
| Commercial handoff | Formula and packaging minimums, sample approval, lead time and shipping terms |
Do Not Equate Berberine With GLP-1 Medication
Berberine formulas require their own ingredient specification, dose feasibility, label review and safety considerations. Expressions such as “natural Ozempic” should not be used as technical evidence or as a promise of equivalent effects. Review the berberine formulation guide for format-specific sourcing decisions.
Capsule Design and Pilot Approval
Confirm shell material, fill compatibility, flow, serving count and packaging. A longer ingredient list does not automatically produce a better product. Require pilot samples that reflect the planned commercial formula and agree how substitutions or source changes will be approved. For general manufacturing controls, see capsule OEM requirements.
Nutrition Products Need Their Own Format
If the concept is meaningful protein intake, a powder may be more practical than capsules because of serving-size limitations. Specify protein source, per-serving protein, taste, mixing behavior, allergens and packaging independently. Do not assume that a capsule concept and a protein powder address the same nutritional brief.
Before Production Release
- Approve ingredient identity, composition and target-market review.
- Confirm realistic serving quantities and capsule count.
- Approve pilot sample, labels, packaging and storage instructions together.
- Require batch-specific release documents and traceability.
- Document payment milestones, shipping terms and reorder expectations.
Frequently Asked Questions
Is a GLP-1-positioned supplement a prescription medicine?
No. Dietary supplements must not be presented as substitutes for prescription GLP-1 medicines or as treatment for disease.
Can every proposed ingredient fit in capsules?
No. Serving requirements, fill weight and daily capsule count must be checked before choosing this format.
What makes supplier quotations comparable?
The same ingredient specifications, serving, capsule count, packaging, test documents, order volume and shipping terms.
Request a formulation and packaging review